We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Sanofi has agreed on a civil settlement with the US Securities and Exchange Commission (SEC) to resolve charges related to allegations of its subsidiaries paying bribes to win contracts.